Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 21-May-2013
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 8 of 8)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
20-May-13 Pechala's Reports Lubomir Pechala ACURA PHARMACEUTICALS INC (ACUR) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
18-May-13 Wright Reports N/A Wright Investors Service Comprehensive Report for Acura Pharmaceuticals, Inc. 41 $471.50 View Abstract
18-May-13 Pechala's Reports Frantisek Pechala ACURA PHARMACEUTICALS INC (ACUR) 12-months forecast 1 $15 View Abstract
17-May-13 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ACURA PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
17-May-13 Ford Investor Services, Inc. N/A Value Graph: ACURA PHARMACEUT -- ACUR 1 $11.50 View Abstract
17-May-13 Ford Investor Services, Inc. N/A Industry Value Graph: ACUR , ANTH , LCI , OMER , PIP , SLXP -- DRUGS 3 $34.50 View Abstract
11-May-13 S&P Capital IQ Quantitative Report N/A Acura Pharmaceuticals 5 $57.50 View Abstract
3-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-generic Drugs 17 $195.50 View Abstract

Independent Reports (Showing 1 to 8 of 8)

Release
Date Contributor Author Title Pages Price More Info
20-May-13 Pechala's Reports Lubomir Pechala ACURA PHARMACEUTICALS INC (ACUR) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
18-May-13 Wright Reports N/A Wright Investors Service Comprehensive Report for Acura Pharmaceuticals, Inc. 41 $471.50 View Abstract
18-May-13 Pechala's Reports Frantisek Pechala ACURA PHARMACEUTICALS INC (ACUR) 12-months forecast 1 $15 View Abstract
17-May-13 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ACURA PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
17-May-13 Ford Investor Services, Inc. N/A Value Graph: ACURA PHARMACEUT -- ACUR 1 $11.50 View Abstract
17-May-13 Ford Investor Services, Inc. N/A Industry Value Graph: ACUR , ANTH , LCI , OMER , PIP , SLXP -- DRUGS 3 $34.50 View Abstract
11-May-13 S&P Capital IQ Quantitative Report N/A Acura Pharmaceuticals 5 $57.50 View Abstract
3-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-generic Drugs 17 $195.50 View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.